Back to Markets
BDBiodesix Inc

Biodesix Inc

BDSXNASDAQ NMS - GLOBAL MARKET
Health CareHealth Care

$16.32

+0.3300 (+2.06%)

As of 05/29/26 EDT · USD

Compare
Low: $5.00Current: $16.32High: $20.21

Key Statistics

Open

$16.24

Day High

$17.21

Day Low

$15.81

Prev. Close

$15.99

VolumeShares traded today.

106.09K

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$164.97M

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-4.05

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$20.21

52W LowLowest price over the past 52 weeks.

$5.00

50D MAAverage closing price over the last 50 trading days.

$13.82

200D MAAverage closing price over the last 200 trading days.

$10.32

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

+7.5%

1M

+65.9%

6M

+110.9%

YTD

+152.6%

1Y

+170.2%

About

VeriStrat is a test developed to evaluate patient prognosis and, additionally, predict benefit from cancer treatment by EGFR inhibitors. It is a serum/plasma proteomic test developed using matrix-assisted laser desorption/ionization (MALDI) mass spectrometry. VeriStrat was developed by Biodesix, Inc., a molecular diagnostics company based in Boulder, Colorado, US.

www.biodesix.com/

Company Facts

SectorHealth Care
IndustryHealth Care
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade BDSX

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.